Related Experiment Video
Updated: Aug 19, 2026

In Vivo Alkaline Comet Assay and Enzyme-modified Alkaline Comet Assay for Measuring DNA Strand Breaks and Oxidative DNA Damage in Rat Liver
Published on: May 4, 2016
Effects of glucosinolate breakdown products on the hepatic biotransformation system in male rats
B Ozierenski1, R Plass, H J Lewerenz
1Deutsches Institut für Ernährungsforschung, Potsdam-Rehbrücke, Bundesrepublik Deutschland.
Abstract:
The effects of 5-vinyloxazolidine-2-thione (VOT), 1-cyano-3-butene (CYB) and various isothiocyanates on parameters of hepatic phase I and phase II biotransformation were investigated in male rats after oral treatment for 3 consecutive days. The compounds with the exception of CYB caused increases in liver weight and glutathione S-transferase activity. Cytochrome P-450 level and monooxygenase activities were decreased by the isothiocyanates and CYB. Administration of VOT resulted in contrasting response of monooxygenases: reduced aminopyrine N-demethylation and enhanced aniline hydroxylation. Possible mechanisms were discussed.
Related Concept Videos
Drug Biotransformation: Overview
Drug Metabolism: Phase II Reactions
Drug Biotransformation: Overview
Phase II Reactions: Glucuronidation
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

